The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5040497 6026598 F 5040497-X 20060328 20060407 20060630 EXP US-ROCHE-443965 ROCHE 51 YR F Y 79.9 KG 20060630 OT UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5040497 1007431419 PS XELODA 1 ORAL FOUR PILLS IN THE MORNING AND THREE PILLS IN THE EVENING. 20896
5040497 1007431420 SS XELODA 1 ORAL 020896
5040497 1007431421 SS XELODA 1 ORAL 020896
5040497 1007431422 I DILANTIN 1 UNKNOWN

Indications of drugs used

Event ID DRUG SEQ INDI PT
5040497 1007431419 BREAST CANCER METASTATIC

Outcome of event

Event ID OUTC COD
5040497 OT

Reactions reported

Event ID PT
5040497 CONVULSION
5040497 DRUG LEVEL INCREASED

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5040497 1007431419 20060310 20060328 19 DAY
5040497 1007431421 20060415
5040497 1007431422 20050915 20060328 195 DAY